M

MDxHealth SA
NASDAQ:MDXH

Watchlist Manager
MDxHealth SA
NASDAQ:MDXH
Watchlist
Price: 1.91 USD -3.54% Market Closed
Market Cap: 90.3m USD
Have any thoughts about
MDxHealth SA?
Write Note

Relative Value

The Relative Value of one MDXH stock under the Base Case scenario is 9.47 USD. Compared to the current market price of 1.91 USD, MDxHealth SA is Undervalued by 80%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MDXH Relative Value
Base Case
9.47 USD
Undervaluation 80%
Relative Value
Price
M
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
85
vs Industry
89
Median 3Y
2.4
Median 5Y
22.1
Industry
8.1
Forward
1
vs History
vs Industry
Median 3Y
-2.8
Median 5Y
-8.4
Industry
23
Forward
-1.5
vs History
vs Industry
22
Median 3Y
7.3
Median 5Y
11.1
Industry
2.6
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
N/A

Multiples Across Competitors

MDXH Competitors Multiples
MDxHealth SA Competitors

All Multiples
P/S
P/E
P/B
All Countries
Close
Market Cap P/S P/E P/B
BE
MDxHealth SA
NASDAQ:MDXH
90.3m USD 0.8 -1.5 -10.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 380 957.8 -177 666.1 -182 762.2
US
Abbvie Inc
NYSE:ABBV
302.3B USD 5.4 59.5 50.1
US
Amgen Inc
NASDAQ:AMGN
160.6B USD 4.9 38 21.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.3B USD 11.9 -263.2 8.1
US
Gilead Sciences Inc
NASDAQ:GILD
118.3B USD 4.2 939 6.4
US
Epizyme Inc
F:EPE
94.1B EUR 1 884.6 -480.9 -4 925.8
AU
CSL Ltd
ASX:CSL
138.5B AUD 6.1 34.3 5.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
90.4B USD 6.5 19.4 3.1
US
Seagen Inc
F:SGT
39.3B EUR 18.2 -55.7 16.4
NL
argenx SE
XBRU:ARGX
33.4B EUR 18.2 -127.9 8.3
P/E Multiple
Earnings Growth
BE
M
MDxHealth SA
NASDAQ:MDXH
Average P/E: 218
Negative Multiple: -1.5
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -177 666.1 N/A
US
Abbvie Inc
NYSE:ABBV
59.5
412%
US
Amgen Inc
NASDAQ:AMGN
38
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -263.2
42%
US
Gilead Sciences Inc
NASDAQ:GILD
939
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -480.9 N/A
AU
CSL Ltd
ASX:CSL
34.3
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.4
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -127.9 N/A

See Also

Discover More
Back to Top